Skip to main content
Premium Trial:

Request an Annual Quote

Boston U Proteomics Lab Using Nonlinear Dynamics' Analysis Software

NEW YORK (GenomeWeb News) – Boston University’s Cardiovascular Proteomics Center Core Laboratory is using Nonlinear Dynamics’ liquid chromatography-mass spectrometry software in its studies, under an early-access agreement, the company said today.
 
UK-based Nonlinear Dynamics said it collaborated with CPC researchers on final development and fine-tuning of its LC-MS v1.1 software. CPC also is using the company’s SameSpots v3.0 software for 2D gel analysis and for LC/MS analysis.
 
CPC already has used Nonlinear's Progenesis software to identify proteomic alterations associated with heart function that may be used to develop therapeutic strategies for treating cardiovascular disease.
 
Nonlinear Dynamics CEO Will Dracup said in a statement that the software can save research time and can reduce the likelihood of sample loss.
 
Financial terms of the agreement were not released.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.